Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00755_DB01320_nanopub.RASXzqs8Jn0OQpF-4OC08s7-y_q3Q1P-K9GVAMvrak2sM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00755_DB01320 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00755_DB01320 label "DDI between Tretinoin and Fosphenytoin - The strong CYP2C8 inducer, Fosphenytoin, may increase the metabolism and clearance of oral Tretinoin. Consider alternate therapy to avoid failure of Tretinoin therapy or monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Fosphenytoin is initiated, discontinued or dose changed. [drugbank_resource:DB00755_DB01320]" assertion.
- drugbank_resource:DB00755_DB01320 identifier "drugbank_resource:DB00755_DB01320" assertion.
- drugbank_resource:DB00755_DB01320 title "DDI between Tretinoin and Fosphenytoin - The strong CYP2C8 inducer, Fosphenytoin, may increase the metabolism and clearance of oral Tretinoin. Consider alternate therapy to avoid failure of Tretinoin therapy or monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Fosphenytoin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01320 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01320 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01320 assertion.